Time-Resolved Transcriptomic Profiling of Surgical Wounds Identifies Stage-Specific Therapeutic Targets for Residual Ovarian Cancer.

birinapant (IGM-9427) - IGM Biosciences

Synribo (omacetaxine mepesuccinate) - Teva

atorvastatin - Generic mfg.

Zolinza (vorinostat) - Merck (MSD)

imatinib - Generic mfg.

LY2090314 - Eli Lilly

ABT-737 - AbbVie

fulvestrant - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/42076065

Insuk Sohn; Jae Ryoung Hwang; Jeong-Won Lee; Ji-Yoon Ryu; Ju-Yeon Choi; Jung-Joo Choi; Mahesh Chandra Patra; Mohamed El-Agamy Farh; Myeong-Seon Kim; Seongyun Lim; Yoo-Young Lee; Young-Jae Cho

May 4, 2026